$SGBX
SAFE & GREEN HOLDINGS CORP. Stock $sgbx

$sgbx Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000121390023087127 Filed on November 14, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q3
Revenue	$1.957M	$3.965M	$4.130M
YoY Change	-52.32%	-3.99%	-53.32%
Cost Of Revenue	$3.941M	$4.501M	$4.295M
YoY Change	-0.05%	4.79%	-50.87%
Gross Profit	-$1.984M	-$536.0K	-$165.2K
YoY Change	-1333.13%	224.53%	-257.2%
Gross Profit Margin	-101.42%	-13.52%	-4.0%
Selling, General & Admin	$4.955M	$1.619M	$1.042M
YoY Change	24.84%	55.37%	-63.2%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$140.1K	$92.98K	$106.3K
YoY Change	4.1%	-12.5%	10.17%
% of Gross Profit
Operating Expenses	$4.966M	$2.439M	$2.337M
YoY Change	24.77%	4.37%	-17.47%
Operating Profit	-$6.950M	-$2.975M	-$2.502M
YoY Change	82.0%	18.9%	-8.23%
Interest Expense	-$1.081M	$738.6K	$52.76K
YoY Change	791.49%	1300.07%	17906.14%
% of Operating Profit
Other Income/Expense, Net	-$67.63K	-$633.0K	-$45.97K
YoY Change	12.83%	1277.17%	91.13%
Pretax Income	-$14.07M	-$3.608M	-$2.548M
YoY Change	249.67%	41.6%	-7.36%
Income Tax	$0.00
% Of Pretax Income
Net Earnings	-$13.60M	-$3.608M	-$2.454M
YoY Change	264.31%	47.06%	-35.95%
Net Earnings / Revenue	-695.01%	-90.99%	-59.41%
Basic Earnings Per Share		-$0.22	-$0.18
Diluted Earnings Per Share	-$15.55	-$0.22	-$182.3K
COMMON SHARES
Basic Shares Outstanding	16.48M shares	16.02M shares	12.05M shares
Diluted Shares Outstanding		16.06M shares	13.46M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$17.45K	$712.9K	$2.118M
YoY Change	-97.01%	-66.34%	-35.63%
Cash & Equivalents	$17.45K	$712.9K	$2.118M
Short-Term Investments
Other Short-Term Assets	$1.902M	$4.001M	$2.585M
YoY Change	-72.07%	54.77%	-87.07%
Inventory	$156.5K	$402.2K	$895.0K
Prepaid Expenses
Receivables	$182.8K	$741.3K	$1.713M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$5.341M	$7.102M	$11.87M
YoY Change	-28.85%	-40.18%	32.67%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.582M	$6.901M	$4.881M
YoY Change	-0.47%	41.39%	-29.62%
Goodwill		$1.309M	$1.309M
YoY Change		0.0%	0.0%
Intangibles	$23.62K	$1.951M	$1.973M
YoY Change	-98.82%	-1.08%
Long-Term Investments	$3.643M	$4.343M	$4.449M
YoY Change	-15.29%	-2.38%	28.39%
Other Assets	$30.59K	$40.79K	$81.57K
YoY Change	-57.14%	-49.99%	-33.34%
Total Long-Term Assets	$11.87M	$18.23M	$17.08M
YoY Change	-37.68%	6.72%	6.96%
TOTAL ASSETS
Total Short-Term Assets	$5.341M	$7.102M	$11.87M
Total Long-Term Assets	$11.87M	$18.23M	$17.08M
Total Assets	$17.21M	$25.33M	$28.96M
YoY Change	-35.19%	-12.51%	16.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$7.490M	$6.193M	$3.494M
YoY Change	138.0%	77.26%	-51.04%
Accrued Expenses	$2.511M	$773.4K	$457.8K
YoY Change	499.82%	68.94%	45.15%
Deferred Revenue	$1.367M	$1.311M	$1.274M
YoY Change	212.62%	2.87%	8.35%
Short-Term Debt	$8.472M	$7.157M	$0.00
YoY Change	219.91%		-100.0%
Long-Term Debt Due	$8.472M	$227.8K	$16.57K
YoY Change	950.11%	1274.47%	-14.37%
Total Short-Term Liabilities	$20.55M	$15.68M	$7.749M
YoY Change	146.8%	102.4%	-28.54%
LONG-TERM LIABILITIES
Long-Term Debt	$2.592M	$2.897M	$750.0K
YoY Change	55.11%	286.28%	4426.25%
Other Long-Term Liabilities	$405.0K	$337.0K	$2.195M
YoY Change	-80.89%	-84.65%	133.33%
Total Long-Term Liabilities	$2.997M	$3.234M	$2.945M
YoY Change	-20.93%	9.8%	207.62%
TOTAL LIABILITIES
Total Short-Term Liabilities	$20.55M	$15.68M	$7.749M
Total Long-Term Liabilities	$2.997M	$3.234M	$2.945M
Total Liabilities	$23.55M	$18.92M	$10.69M
YoY Change	94.34%	76.89%	-9.38%
SHAREHOLDERS EQUITY
Retained Earnings	-$75.93M	-$62.33M	-$37.70M
YoY Change	83.28%	65.36%	26.99%
Common Stock	$8.814K	$164.8K	$120.5K
YoY Change	-93.01%	36.78%	36.58%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$92.40K	$92.40K	$49.68K
YoY Change	85.98%	85.98%
Treasury Stock Shares			23.12K shares
Shareholders Equity	-$7.459M	$5.502M	$17.63M
YoY Change
Total Liabilities & Shareholders Equity	$17.21M	$25.33M	$28.96M
YoY Change	-35.19%	-12.51%	16.19%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2022 Q3
OPERATING ACTIVITIES
Net Income	-$13.60M	-$3.608M	-$2.454M
YoY Change	264.31%	47.06%	-35.95%
Depreciation, Depletion And Amortization	$140.1K	$92.98K	$106.3K
YoY Change	4.1%	-12.5%	10.17%
Cash From Operating Activities	-$2.470M	-$1.632M	-$190.6K
YoY Change	3089.01%	756.13%	-169.18%
INVESTING ACTIVITIES
Capital Expenditures	$172.2K	$9.940K	-$244.2K
YoY Change	-79.29%	-104.07%	115.4%
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$12.66K	-$227.5K
YoY Change	-100.0%	-94.44%	-411.4%
Cash From Investing Activities	-$172.2K	-$22.60K	-$471.7K
YoY Change	-43.34%	-95.21%	1070.28%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.947M	764.6K	352.3K
YoY Change	-268.68%	117.02%	-51.86%
NET CHANGE
Cash From Operating Activities	-2.470M	-1.632M	-190.6K
Cash From Investing Activities	-172.2K	-22.60K	-471.7K
Cash From Financing Activities	1.947M	764.6K	352.3K
Net Change In Cash	-695.5K	-889.9K	-310.0K
YoY Change	-54.7%	187.02%	-132.06%
FREE CASH FLOW
Cash From Operating Activities	-$2.470M	-$1.632M	-$190.6K
Capital Expenditures	$172.2K	$9.940K	-$244.2K
Free Cash Flow	-$2.642M	-$1.642M	$53.59K
YoY Change	190.63%	-3163.63%	-86.22%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Trading Symbol TradingSymbol	SGBX
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Central Index Key EntityCentralIndexKey	0001023994
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-38037
	dei	Entity Registrant Name EntityRegistrantName	SAFE & GREEN HOLDINGS CORP.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	95-4463937
	dei	Entity Address Address Line1 EntityAddressAddressLine1	990 Biscayne Blvd.,
	dei	Entity Address Address Line2 EntityAddressAddressLine2	#501, Office 12
	dei	Entity Address City Or Town EntityAddressCityOrTown	Miami
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33132
	dei	City Area Code CityAreaCode	(646)
	dei	Local Phone Number LocalPhoneNumber	240-4235
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.01 per share
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	16482771	shares
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	712906	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	582776	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	741299	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1280456	usd
CY2023Q3	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	18391	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	36384	usd
CY2023Q3	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	4400361	usd
CY2022Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	4396826	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	402186	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	465560	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	826917	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	744211	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	7102060	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	7506213	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6901417	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5608903	usd
CY2023Q3	sgbx	Project Development Costs And Other Non Current Assets ProjectDevelopmentCostsAndOtherNonCurrentAssets	603431	usd
CY2022Q4	sgbx	Project Development Costs And Other Non Current Assets ProjectDevelopmentCostsAndOtherNonCurrentAssets	483546	usd
CY2023Q3	us-gaap	Goodwill Goodwill	1309330	usd
CY2022Q4	us-gaap	Goodwill Goodwill	1309330	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2203659	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4421002	usd
CY2023Q3	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	879418	usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	857534	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1951367	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1997833	usd
CY2023Q3	us-gaap	Deferred Costs DeferredCosts	40785	usd
CY2022Q4	us-gaap	Deferred Costs DeferredCosts	71374	usd
CY2023Q3	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	700000	usd
CY2022Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	700000	usd
CY2023Q3	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	3642607	usd
CY2022Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	3599945	usd
CY2023Q3	us-gaap	Assets Assets	25334074	usd
CY2022Q4	us-gaap	Assets Assets	26555680	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	6193349	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4009522	usd
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1311002	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	437271	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1001138	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1225394	usd
CY2023Q3	us-gaap	Liabilities Of Business Transferred Under Contractual Arrangement Current LiabilitiesOfBusinessTransferredUnderContractualArrangementCurrent	20795	usd
CY2022Q4	us-gaap	Liabilities Of Business Transferred Under Contractual Arrangement Current LiabilitiesOfBusinessTransferredUnderContractualArrangementCurrent	5795	usd
CY2023Q3	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	7156737	usd
CY2022Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	2648300	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	15683021	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8326282	usd
CY2023Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	2500000	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	750000	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	734027	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3039836	usd
CY2023Q3	us-gaap	Liabilities Liabilities	18917048	usd
CY2022Q4	us-gaap	Liabilities Liabilities	12116118	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5405010	shares
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5405010	shares
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16482771	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15948789	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12613978	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12590863	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	164828	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	126140	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	67760551	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	56173977	usd
CY2023Q3	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	67318	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	23115	shares
CY2023Q3	us-gaap	Treasury Stock Value TreasuryStockValue	92396	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	49680	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-62331370	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-41428268	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	5501613	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	14822169	usd
CY2023Q3	us-gaap	Minority Interest MinorityInterest	915413	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	-382607	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6417026	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	14439562	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	25334074	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	26555680	usd
CY2023Q3	us-gaap	Revenues Revenues	3965361	usd
CY2022Q3	us-gaap	Revenues Revenues	4130257	usd
	us-gaap	Revenues Revenues	14566351	usd
	us-gaap	Revenues Revenues	20289826	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	4501393	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	4295431	usd
	us-gaap	Cost Of Revenue CostOfRevenue	15138225	usd
	us-gaap	Cost Of Revenue CostOfRevenue	17196605	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	-536032	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	-165174	usd
	us-gaap	Gross Profit GrossProfit	-571874	usd
	us-gaap	Gross Profit GrossProfit	3093221	usd
CY2023Q3	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	819909	usd
CY2022Q3	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	1294857	usd
	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	6318728	usd
	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	3650553	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1353866	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	939044	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4499982	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2515877	usd
CY2023Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	265313	usd
CY2022Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	103111	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	455463	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	337941	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	2439088	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	2337012	usd
	us-gaap	Operating Expenses OperatingExpenses	11274173	usd
	us-gaap	Operating Expenses OperatingExpenses	6504371	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2975120	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2502186	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-11846047	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3411150	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	738649	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	52758	usd
	us-gaap	Interest Expense InterestExpense	1549992	usd
	us-gaap	Interest Expense InterestExpense	174733	usd
CY2023Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	3186	usd
CY2022Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	9756	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	22002	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	33518	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	102449	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2963	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	690939	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	488346	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-633014	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-45965	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-837051	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	347131	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3608134	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2548151	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-12683098	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3064019	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-3608134	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-2548151	usd
	us-gaap	Profit Loss ProfitLoss	-12683098	usd
	us-gaap	Profit Loss ProfitLoss	-3064019	usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2022Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-94568	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1522101	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-3608134	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2453583	usd
	us-gaap	Net Income Loss NetIncomeLoss	-12683098	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4586120	usd
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.22
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.86
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.86
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.35
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.35
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16057132	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16057132	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13459713	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13459713	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14761502	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14761502	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13228828	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13228828	shares
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9325160	usd
CY2023Q3	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance		usd
CY2023Q3	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	700000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-3608134	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6417026	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	14439562	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3210631	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	437325	usd
	sgbx	Stock Issued During Period Value Restricted Stock Units Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockUnitsNetOfForfeitures		usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	47500	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	354239	usd
	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	46417	usd
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	42716	usd
	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	700000	usd
	us-gaap	Profit Loss ProfitLoss	-12683098	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6417026	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	20364083	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	594694	usd
CY2022Q3	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	98000	usd
CY2022Q3	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	49680	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-2548151	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	18262946	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	21715789	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1914856	usd
	sgbx	Stock Issued During Period Value Restricted Stock Units Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockUnitsNetOfForfeitures		usd
	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	2254000	usd
	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	49680	usd
	us-gaap	Profit Loss ProfitLoss	-3064019	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	18262946	usd
	us-gaap	Profit Loss ProfitLoss	-12683098	usd
	us-gaap	Profit Loss ProfitLoss	-3064019	usd
	us-gaap	Depreciation Depreciation	277648	usd
	us-gaap	Depreciation Depreciation	317249	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	140437	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	122587	usd
	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	30589	usd
	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	30589	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	685308	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	23726	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	613092	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense		usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	484825	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	7024	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	21884	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	28048	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	3210631	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1874857	usd
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets		usd
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-241	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-539157	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1197149	usd
	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets		usd
	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	2000000	usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-17993	usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-41916	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-63374	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-378863	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	82710	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	35845	usd
	us-gaap	Increase Decrease In Intangible Assets Current IncreaseDecreaseInIntangibleAssetsCurrent	93971	usd
	us-gaap	Increase Decrease In Intangible Assets Current IncreaseDecreaseInIntangibleAssetsCurrent		usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets		usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-356350	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2183831	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-4006868	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	873731	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-163161	usd
	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent		usd
	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	-264451	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-925815	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-341319	usd
	sgbx	Increase Decrease In Assumed Liability Of Business Transferred IncreaseDecreaseInAssumedLiabilityOfBusinessTransferred	15000	usd
	sgbx	Increase Decrease In Assumed Liability Of Business Transferred IncreaseDecreaseInAssumedLiabilityOfBusinessTransferred		usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4671862	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5553160	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	530057	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1996200	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	760	usd
	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties		usd
	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties	100000	usd
	us-gaap	Payments To Acquire In Process Research And Development PaymentsToAcquireInProcessResearchAndDevelopment	119885	usd
	us-gaap	Payments To Acquire In Process Research And Development PaymentsToAcquireInProcessResearchAndDevelopment	805362	usd
	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	42662	usd
	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	148570	usd
	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments		usd
	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	500000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-692604	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3549372	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	42716	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	49680	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	2732144	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	7609514	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	500000	usd
	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	706359	usd
	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt		usd
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	46417	usd
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	2254000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5494596	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1803680	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	130130	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-10906212	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	582776	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13024381	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	712906	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2118169	usd
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred		usd
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	1801584	usd
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	700000	usd
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1		usd
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	4	segments
CY2023Q3	sgbx	Number Of Core Product Offerings NumberOfCoreProductOfferings	3	number
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	712906	usd
CY2023Q3	us-gaap	Other Assets Current OtherAssetsCurrent	4000771	usd
CY2023Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	4000771	usd
	sgbx	Working Capital WorkingCapital	-9280961	usd
CY2023Q3	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	203926	usd
CY2023Q3	us-gaap	Accumulated Amortization Of Other Deferred Costs AccumulatedAmortizationOfOtherDeferredCosts	163140	usd
	sgbx	Deferred Contract Costs Amortization Expense DeferredContractCostsAmortizationExpense	30589	usd
	sgbx	Deferred Contract Costs Amortization Expense DeferredContractCostsAmortizationExpense	30589	usd
CY2023Q3	sgbx	Estimated Income Loss On Uncompleted Contracts EstimatedIncomeLossOnUncompletedContracts	103251	usd
CY2022Q4	sgbx	Estimated Income Loss On Uncompleted Contracts EstimatedIncomeLossOnUncompletedContracts	-2160085	usd
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family: 'times new roman', times; font-size: 10pt;"> <div> <div> <div> <p style="color: #000000; font: 10pt 'Times New Roman', Times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0pt 0px 0pt 0.5in;"><span style="font-size: 10pt; line-height: inherit;"><span style="color: black;"><span style="border-left: none; border-right: none; line-height: inherit;"><span style="border-right: none; border-left: none; line-height: inherit;"><b><i>Accounting estimates<span style="line-height: inherit;"> </span></i></b>– The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates, judgements and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period, together with amounts disclosed in the related notes to the financial statements. <span style="font-family: 'times new roman', times; line-height: inherit;">The Company's estimates used in these financial statements include, but are not limited to, revenue recognition, stock-based compensation, accounts receivable reserves, inventory valuations, goodwill, the valuation allowance related to the Company’s deferred tax assets, the carrying amount of intangible assets, right of use assets and the recoverability and useful lives of long-lived assets. Certain of the Company’s estimates could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company’s estimates and could cause actual results to differ from those estimates.</span></span></span></span></span></p> </div> </div> </div> </div>
	sgbx	No Of Operating Cycles NoOfOperatingCycles	one year
	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	0	usd
	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	10200000	usd
	sgbx	Revenue Recognized At Point In Time RevenueRecognizedAtPointInTime	0	usd
	sgbx	Revenue Recognized Over Time RevenueRecognizedOverTime	14566351	usd
	sgbx	Revenue Recognized At Point In Time RevenueRecognizedAtPointInTime	11640953	usd
	sgbx	Revenue Recognized Over Time RevenueRecognizedOverTime	8648873	usd
CY2023Q3	sgbx	Revenue Recognized At Point In Time RevenueRecognizedAtPointInTime	0	usd
CY2023Q3	sgbx	Revenue Recognized Over Time RevenueRecognizedOverTime	3965361	usd
CY2022Q3	sgbx	Revenue Recognized At Point In Time RevenueRecognizedAtPointInTime	1437738	usd
CY2022Q3	sgbx	Revenue Recognized Over Time RevenueRecognizedOverTime	2692519	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3965361	usd
CY2023Q3	sgbx	Revenue From Contract With Customer Excluding Assessed Tax Percentage RevenueFromContractWithCustomerExcludingAssessedTaxPercentage	1	pure
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4130257	usd
CY2022Q3	sgbx	Revenue From Contract With Customer Excluding Assessed Tax Percentage RevenueFromContractWithCustomerExcludingAssessedTaxPercentage	1	pure
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	14566351	usd
	sgbx	Revenue From Contract With Customer Excluding Assessed Tax Percentage RevenueFromContractWithCustomerExcludingAssessedTaxPercentage	1	pure
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	20289826	usd
	sgbx	Revenue From Contract With Customer Excluding Assessed Tax Percentage RevenueFromContractWithCustomerExcludingAssessedTaxPercentage	1	pure
CY2023Q3	us-gaap	Deferred Costs And Other Assets DeferredCostsAndOtherAssets	102217	usd
CY2020Q3	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	200000	shares
	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	712906	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	582776	usd
CY2023Q3	us-gaap	Short Term Investments ShortTermInvestments	0	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	0	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	189019	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	171684	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	168006	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	1180852	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1951367	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023Q3	us-gaap	Finite Lived Trademarks Gross FiniteLivedTrademarksGross	68344	usd
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1121399	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	938319	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	140437	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	122587	usd
CY2023Q3	us-gaap	Adjustment For Amortization AdjustmentForAmortization	47027	usd
CY2022Q3	us-gaap	Adjustment For Amortization AdjustmentForAmortization	39243	usd
CY2023Q3	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P5Y
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	49370	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	192436	usd
CY2022Q4	sgbx	Provision For Loss On Uncompleted Contracts ProvisionForLossOnUncompletedContracts		usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="margin: 0pt 0pt 0pt 36pt; text-align: justify; line-height: 1.2;"><span style="font-size: 10pt; line-height: inherit;"><span style="font-family: 'Times New Roman'; font-style: italic; font-weight: bold; line-height: inherit;">Concentrations of credit risk </span><span style="font-family: 'Times New Roman'; font-style: italic; line-height: inherit;">–</span><span style="font-family: 'Times New Roman'; line-height: inherit;"> Financial instruments, that potentially subject the Company to concentration of credit risk, consist principally of cash and cash equivalents. The Company places its cash with high credit quality institutions. At times, such amounts may be in excess of the FDIC insurance limits. The Company has not experienced any losses in such account and believes that it is not exposed to any </span><span style="font-family: 'Times New Roman'; line-height: inherit;">significant </span><span style="font-family: 'Times New Roman'; line-height: inherit;">credit risk on the account. <br/></span><span style="font-family: 'Times New Roman'; line-height: inherit;"> </span></span></p> <p style="margin: 0pt 0pt 0pt 36pt; text-align: justify; line-height: 1.2;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">With respect to receivables, concentrations of credit risk are limited to a few customers in the construction industry. The Company performs ongoing credit evaluations of its customers’ financial condition and, generally, requires no collateral from its customers other than normal lien rights. At <span>September 30, 2023</span> and <span>December 31, 2022</span>, 87% and 80%, respectively, of the Company’s gross accounts receivable were due from <span style="border-left: none; border-right: none; line-height: inherit;">three</span> and three customers. </span></p> <p style="margin: 0pt 0pt 0pt 36pt; text-align: justify; line-height: 1.2;"><br/></p> <p style="margin: 0pt 0pt 0pt 36pt; text-align: justify; line-height: 1.2;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">Revenue relating to one and two customers represented approximately 100% and 93% of the Company's total revenue for the <span style="line-height: inherit;"><span style="font-family: 'Times New Roman', 'serif'; line-height: inherit;"><span>three months ended September 30, 2023</span></span></span><span style="line-height: inherit;"><span style="font-family: 'Times New Roman', 'serif'; line-height: inherit;"> and </span></span><span style="line-height: inherit;"><span style="font-family: 'Times New Roman', 'serif'; line-height: inherit;"><span style="border-left: none; border-right: none; line-height: inherit;"><span>2022</span></span></span></span><span style="line-height: inherit;"><span style="font-family: 'Times New Roman', 'serif'; line-height: inherit;">, respectively. <span style="color: #000000; font-family: 'times new roman', times; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; line-height: inherit;"><span style="font-family: 'Times New Roman', 'serif'; line-height: inherit;">Revenue relating to </span></span><span style="color: #000000; font-family: 'times new roman', times; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; line-height: inherit;"><span style="font-family: 'Times New Roman', 'serif'; line-height: inherit;">one</span></span><span style="color: #000000; font-family: 'times new roman', times; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; line-height: inherit;"><span style="font-family: 'Times New Roman', 'serif'; line-height: inherit;"> and </span></span><span style="color: #000000; font-family: 'times new roman', times; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; line-height: inherit;"><span style="font-family: 'Times New Roman', 'serif'; line-height: inherit;">one</span></span><span style="color: #000000; font-family: 'times new roman', times; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; line-height: inherit;"><span style="font-family: 'Times New Roman', 'serif'; line-height: inherit;"> customers represented approximately 97</span></span><span style="color: #000000; font-family: 'times new roman', times; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; line-height: inherit;"><span style="font-family: 'Times New Roman', 'serif'; line-height: inherit;">% and </span></span><span style="color: #000000; font-family: 'times new roman', times; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; line-height: inherit;"><span style="font-family: 'Times New Roman', 'serif'; line-height: inherit;">88</span></span><span style="color: #000000; font-family: 'times new roman', times; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; line-height: inherit;"><span style="font-family: 'Times New Roman', 'serif'; line-height: inherit;">% of the Company's total revenue for the </span></span><span style="color: #000000; font-family: 'times new roman', times; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;"><span>nine months ended September 30, 2023</span> and <span>2022</span>, respectively.</span></span></span></span></p> <p style="margin: 0pt 0pt 0pt 36pt; text-align: justify; line-height: 1.2;"><br/></p> <p style="margin: 0in 0in 0in 0.5in; text-align: justify; line-height: 12pt; font-size: 10pt; font-family: 'Times New Roman', serif;"><span style="font-size: 10pt; color: #000000; font-family: 'times new roman', times; line-height: inherit;">There were no vendors representing 10% or more of the Company’s total cost of revenue for the <span>three and nine</span> months ended <span>September 30, 2023</span> and 2022. The Company believes it has access to alternative suppliers, with limited disruption to the business, should circumstances change with its existing suppliers.</span></p>
CY2023Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	887045	usd
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	1426202	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	145746	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	741299	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1280456	usd
CY2023Q3	sgbx	Costs Incurred On Uncompleted Contracts CostsIncurredOnUncompletedContracts	17242167	usd
CY2022Q4	sgbx	Costs Incurred On Uncompleted Contracts CostsIncurredOnUncompletedContracts	13730177	usd
CY2023Q3	sgbx	Provision For Loss On Uncompleted Contracts ProvisionForLossOnUncompletedContracts		usd
CY2023Q3	sgbx	Contract Assets Gross ContractAssetsGross	17345418	usd
CY2022Q4	sgbx	Contract Assets Gross ContractAssetsGross	11570092	usd
CY2023Q3	sgbx	Costs In Excess Of Billings To Date CostsInExcessOfBillingsToDate	18638029	usd
CY2022Q4	sgbx	Costs In Excess Of Billings To Date CostsInExcessOfBillingsToDate	11970979	usd
CY2023Q3	sgbx	Contract With Customer Net Asset Liability ContractWithCustomerNetAssetLiability	-1292611	usd
CY2022Q4	sgbx	Contract With Customer Net Asset Liability ContractWithCustomerNetAssetLiability	-400887	usd
CY2023Q3	sgbx	Contract With Customer Assets Net Current ContractWithCustomerAssetsNetCurrent	18391	usd
CY2022Q4	sgbx	Contract With Customer Assets Net Current ContractWithCustomerAssetsNetCurrent	36384	usd
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1311002	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	437271	usd
CY2023Q3	sgbx	Contract With Customer Net Asset Liability ContractWithCustomerNetAssetLiability	-1292611	usd
CY2022Q4	sgbx	Contract With Customer Net Asset Liability ContractWithCustomerNetAssetLiability	-400887	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7897791	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6327629	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	996374	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	718726	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6901417	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5608903	usd
CY2023Q3	us-gaap	Depreciation Depreciation	92984	usd
CY2022Q3	us-gaap	Depreciation Depreciation	106271	usd
	us-gaap	Depreciation Depreciation	277648	usd
	us-gaap	Depreciation Depreciation	317249	usd
CY2021Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	2000000	usd
CY2021Q3	us-gaap	Proceeds From Construction Loans Payable ProceedsFromConstructionLoansPayable	1948234	usd
CY2021Q3	us-gaap	Debt Instrument Term DebtInstrumentTerm	P1Y
CY2021Q3	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.12	pure
CY2021Q3	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.005	pure
CY2022	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	20000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	4134	usd
CY2022Q3	us-gaap	Proceeds From Subordinated Short Term Debt ProceedsFromSubordinatedShortTermDebt	500000	usd
CY2021Q4	sgbx	Value Of Renovation Improvements ValueOfRenovationImprovements	750000	usd
CY2021Q4	sgbx	Principal Amount Of Promissory Note PrincipalAmountOfPromissoryNote	750000	usd
CY2023Q3	sgbx	Operating Lease Right Of Use Assets OperatingLeaseRightOfUseAssets	628181	usd
CY2023Q3	sgbx	Operating Lease Liabilities Current OperatingLeaseLiabilitiesCurrent	227753	usd
CY2023Q3	sgbx	Operating Lease Liabilities Noncurrent OperatingLeaseLiabilitiesNoncurrent	397067	usd
CY2023Q3	sgbx	Total Operating Lease Liabilities TotalOperatingLeaseLiabilities	624820	usd
CY2023Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	1575478	usd
CY2023Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	773385	usd
CY2023Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	336960	usd
CY2023Q3	sgbx	Total Finance Lease Liabilities TotalFinanceLeaseLiabilities	1110345	usd
CY2023Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y
CY2023Q3	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P1Y3M3D
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.03	pure
CY2023Q3	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.03	pure
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	81000	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	400934	usd
CY2023Q3	us-gaap	Other Commitments Future Minimum Payments Remainder Of Fiscal Year OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear	481934	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	324000	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	801869	usd
CY2023Q3	us-gaap	Other Commitment Due In Next Twelve Months OtherCommitmentDueInNextTwelveMonths	1125869	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	243000	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	133645	usd
CY2023Q3	us-gaap	Other Commitment Due In Second Year OtherCommitmentDueInSecondYear	376645	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	648000	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	1336448	usd
CY2023Q3	us-gaap	Other Commitment OtherCommitment	1984448	usd
CY2023Q3	sgbx	Total Operating Imputed Interest TotalOperatingImputedInterest	24910	usd
CY2023Q3	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	34452	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	59362	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	623090	usd
CY2023Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	1301996	usd
CY2023Q3	sgbx	Presentvalueofleaseliabilities Presentvalueofleaseliabilities	1925086	usd
CY2022Q4	sgbx	Construction Contracts Backlog ConstructionContractsBacklog	6810762	usd
CY2021Q4	sgbx	Construction Contracts Backlog ConstructionContractsBacklog	3217909	usd
	sgbx	New Contracts Received During Year NewContractsReceivedDuringYear	11756360	usd
CY2022	sgbx	New Contracts Received During Year NewContractsReceivedDuringYear	13803733	usd
	sgbx	Adjustments And Cancellations Net AdjustmentsAndCancellationsNet		usd
CY2022	sgbx	Adjustments And Cancellations Net AdjustmentsAndCancellationsNet	-1086301	usd
	sgbx	Construction Backlog Gross ConstructionBacklogGross	18567122	usd
CY2022	sgbx	Construction Backlog Gross ConstructionBacklogGross	18107943	usd
	sgbx	Contract Revenue ContractRevenue	14566351	usd
CY2022	sgbx	Contract Revenue ContractRevenue	11297181	usd
CY2023Q3	sgbx	Construction Contracts Backlog ConstructionContractsBacklog	4000771	usd
CY2022Q4	sgbx	Construction Contracts Backlog ConstructionContractsBacklog	6810762	usd
CY2023Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	4000771	usd
CY2021Q4	sgbx	Gross Proceeds GrossProceeds	11550000	usd
CY2021Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	10500000	usd
CY2019Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	45000	shares
CY2019Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	17
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	73700	shares
CY2023Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	73700	shares
CY2023Q3	sgbx	Stock Based Compensation Expense Total StockBasedCompensationExpenseTotal		usd
	sgbx	Stock Based Compensation Expense Total StockBasedCompensationExpenseTotal	3210631	usd
	sgbx	Stock Based Compensation Expense Total StockBasedCompensationExpenseTotal	1874857	usd
CY2023Q3	sgbx	Stock Based Compensation Expense Total StockBasedCompensationExpenseTotal		usd
CY2022Q3	sgbx	Stock Based Compensation Expense Total StockBasedCompensationExpenseTotal	594694	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	36436	shares
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	24.8
CY2022Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	78.71
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y4M2D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	sgbx	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue
	sgbx	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised In Period Weighted Average Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodWeightedAverageFairValue
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	36436	shares
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	24.8
CY2023Q3	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	78.71
	sgbx	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm	P3Y10M2D
CY2023Q3	sgbx	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value One ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueOne		usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	36436	shares
CY2022Q4	sgbx	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableInPeriodWeightedAverageGrantDateFairValue	24.8
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	78.71
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y4M2D
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	36436	shares
CY2023Q3	sgbx	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableInPeriodWeightedAverageGrantDateFairValue	24.8
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	78.71
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y10M2D
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
CY2023Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	0	usd
CY2023Q3	us-gaap	Share Price SharePrice	0.6
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1190935	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	585000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	1775935	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod		shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber		shares
CY2018Q3	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	761401.66	usd
CY2020Q1	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	2861401.66	usd
CY2019Q2	sgbx	Unpaid Wages UnpaidWages	30429	usd
CY2021Q3	sgbx	Recovery Of Damages Sought RecoveryOfDamagesSought	67125.83	usd
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001213900-23-087127-index-headers.html	Edgar Link	pending
0001213900-23-087127-index.html	Edgar Link	pending
0001213900-23-087127.txt	Edgar Link	pending
0001213900-23-087127-xbrl.zip	Edgar Link	pending
ex311_1.htm	Edgar Link	pending
ex312_2.htm	Edgar Link	pending
ex321_3.htm	Edgar Link	pending
ex322_4.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sgbx-20230930.htm	Edgar Link	pending
sgbx-20230930.xsd	Edgar Link	pending
Show.js	Edgar Link	pending
sgbx-20230930_cal.xml	Edgar Link	unprocessable
sgbx-20230930_def.xml	Edgar Link	unprocessable
sgbx-20230930_lab.xml	Edgar Link	unprocessable
sgbx-20230930_pre.xml	Edgar Link	unprocessable
sgbx-20230930_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SGBX
SAFE & GREEN HOLDINGS CORP. Stock $sgbx

2023 Q4 Form 10-Q Financial Statement

#000121390023087127 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SGBX SAFE & GREEN HOLDINGS CORP. Stock $sgbx

2023 Q4 Form 10-Q Financial Statement

#000121390023087127 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SGBX
SAFE & GREEN HOLDINGS CORP. Stock $sgbx